Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(adenosine diphosphoribose)transferase, nicotinamide adenine dinucleotide-arginine
-
-
-
-
actin-specific ADP-ribosyltransferase
-
ADP-ribosyl-acceptor hydrolase 1
-
-
ADP-ribosyltransferase enzymatic component
-
ADP-ribosyltransferase-2
-
-
alloantigen Rt6.1
-
-
-
-
alloantigen Rt6.2
-
-
-
-
arginine ADP-ribosyltransferase 1
arginine specific ADP-ribosyltransferase
-
-
-
-
arginine specific mono-ADP-ribosyltransferase
-
-
-
-
arginine-specific adenosine diphosphate ribosyltransferase 1
-
-
arginine-specific ADP-ribosyltransferase
arginine-specific ADP-ribosyltransferase 1
-
arginine-specific ADP-ribosytransferases 1
-
-
arginine-specific mono-ADP-ribosyltransferase
arginine-specific mono-ADP-ribosyltransferase 1
-
-
arginine-specific mono-ADP-ribosyltransferase A
Meleagris sp.
-
-
asparagine-specific ADP-ribosyltransferase
-
-
binary toxin component Ia
-
-
cARTC2.1
-
bi-functional: NAD-glycohydrolase and arginine-specific ADP-ribosyltransferase activities
CD196 ADP-ribosyltransferase
CTA
-
cholera toxin A subunit
Dombrock blood group carrier molecule
-
-
-
-
glycosylphosphatidylinositol-anchored arginine-specific ADP-ribosyltransferase7.1
-
-
mono(ADP-ribosyl)transferase
-
-
-
-
mono-ADP-ribosyl-arginine hydrolase
-
-
mono-ADP-ribosyltransferase
mono-ADP-ribosyltransferase A
Meleagris sp.
-
-
NAD(P)+-arginine ADP-ribosyltransferase
-
-
-
-
NAD+:arginine ADP-ribosyltransferase
-
-
-
-
NAD+:arginine ecto-mono(ADP-ribosyl)transferase
-
-
-
-
NAD+:L-arginine ADP-D-ribosyltransferase
-
-
-
-
NAD-arginine ADP-ribosyltransferase
-
-
-
-
NAD-arginine mono-ADP-ribosyltransferase B
-
-
-
-
NAD-dependent ADPribosyltransferase
-
-
-
-
NAD:arginine ADP-ribosyltransferase
-
-
NAD:arginine ADP-ribosyltransferase B
-
-
-
-
T-cell surface protein Rt6.1
-
-
-
-
T-cell surface protein Rt6.2
-
-
-
-
ADP-ribosyltransferase

-
-
-
-
ADP-ribosyltransferase
-
-
ADP-ribosyltransferase
-
-
ADP-ribosyltransferase
Tequatrovirus T4
-
-
ADP-ribosyltransferase
-
-
ADPRT

-
-
-
-
arginine ADP-ribosyltransferase 1

-
-
arginine ADP-ribosyltransferase 1
-
-
arginine ADP-ribosyltransferase 1
-
arginine-specific ADP-ribosyltransferase

-
-
arginine-specific ADP-ribosyltransferase
-
-
arginine-specific ADP-ribosyltransferase
-
-
arginine-specific mono-ADP-ribosyltransferase

-
-
-
-
arginine-specific mono-ADP-ribosyltransferase
-
arginine-specific mono-ADP-ribosyltransferase
-
-
arginine-specific mono-ADP-ribosyltransferase
-
-
arginine-specific mono-ADP-ribosyltransferase
-
arginine-specific mono-ADP-ribosyltransferase
-
-
ART

-
-
-
-
ART1

-
-
ART4

-
CD196 ADP-ribosyltransferase

-
CD196 ADP-ribosyltransferase
-
-
CDT

-
-
CdtA

-
cholera toxin

-
-
iota toxin

-
-
mono-ADP-ribosyltransferase

-
mono-ADP-ribosyltransferase
-
-
mono-ADP-ribosyltransferase
-
NarE

-
-
VIP2

-
-
VIP2
the A component of the binary toxin
XAC3230

-
XopAI

-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
A1 peptide of cholera toxin + NAD+
nicotinamide + ?
-
four mol of ADP-ribose are incorporated into 1 mol of A1 peptide. Modification of the A1 peptide increases its enzymatic activity up to 4fold
-
-
?
actin + NAD+
nicotinamide + ?
agmatine + NAD+
nicotinamide + ?
arginine + NAD+
nicotinamide + ADP-ribose-L-arginine
-
-
-
-
?
basic fibroblast growth factor FGF-2 + NAD+
nicotinamide + ?
beta-lactoglobulin + NAD+
nicotinamide + ?
-
-
-
-
?
bovine plasma albumin + NAD+
nicotinamide + ?
-
-
-
-
?
bovine serum albumin + NAD+
nicotinamide + ?
-
poor ADP-ribose acceptor
-
-
?
casein + NAD+
nicotinamide + ?
diethylamino-(benzylidineamino)guanidine + NAD+
nicotinamide + ?
-
-
-
-
?
DNase I + NAD+
nicotinamide + ?
-
-
-
-
?
guanidine + NAD+
nicotinamide + ?
-
-
-
-
?
guanidinobutyrate + NAD+
nicotinamide + ?
-
-
-
-
?
guanidinopropionate + NAD+
nicotinamide + ?
-
-
-
-
?
histone + NAD+
nicotinamide + ?
histone + NAD+
Nomega-[(2'-phospho-ADP)-D-ribosyl]-histone-L-arginine + nicotinamide + H+
-
isozyme ART2 is active with high and low molecular weight histones, membrane-bound and PI-PLC released ART2 preferentially ADP-ribosylate high or low MW histones, respectively
-
-
?
histone f1 + NAD+
nicotinamide + ?
-
-
-
-
?
histone f2a + NAD+
nicotinamide + ?
-
-
-
-
?
histone f2b + NAD+
nicotinamide + ?
-
-
-
-
?
histone f3 + NAD+
nicotinamide + ?
-
-
-
-
?
histone H2B + NAD+
Nomega-[(2'-phospho-ADP)-D-ribosyl]-histone H2B-L-arginine + nicotinamide
Meleagris sp.
-
-
-
-
?
human alpha-defensin-1 + NAD+
nicotinamide + ?
human alpha-globulin + NAD+
nicotinamide + ?
-
-
-
-
?
human beta-defensin-1 + NAD+
nicotinamide + ?
-
-
-
-
?
human beta-globulin + NAD+
nicotinamide + ?
-
-
-
-
?
human gamma-globulin + NAD+
nicotinamide + ?
-
-
-
-
?
human neutrophil peptide-1 + NAD+
Nomega-(ADP-D-ribosyl)-L-arginine-human neutrophil peptide-1 + nicotinamide
karyopherin-beta1 + NAD+
nicotinamide + ?
-
-
-
?
L-arginine methyl ester + NAD+
nicotinamide + Nomega-(ADP-D-ribosyl)-L-arginine
L-arginine methyl ester + NADP+
nicotinamide + N2-(2'-phospho-ADP-D-ribosyl)-L-arginine
-
-
-
-
?
lysozyme + NAD+
nicotinamide + ?
NAD+ + (ADP-D-ribosyl)n-acceptor
nicotinamide + (ADP-D-ribosyl)n+1-acceptor
-
agmatine as ADPribose acceptor is used
-
-
?
NAD+ + actin
nicotinamide + H+ + (ADP-ribosyl)-actin
NAD+ + agmatine
nicotinamide + Nomega-(ADP-D-ribosyl)-agmatine
NAD+ + alpha-actin-L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-alpha-actin-L-arginine
-
skeletal muscle alpha actin
-
-
?
NAD+ + beta-actin
nicotinamide + H+ + (ADP-ribosyl)-beta-actin
-
modification occurs at residue Arg177
-
?
NAD+ + beta/gamma-actin-L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-beta/gamma-actin-L-arginine
-
non-muscle beta/gamma actin
-
-
?
NAD+ + eEF2 L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-eEF2-L-arginine
-
-
-
?
NAD+ + gamma-actin
nicotinamide + H+ + (ADP-ribosyl)-gamma-actin
-
modification occurs at residue Arg177
-
?
NAD+ + gamma-actin-L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-gamma-actin-L-arginine
-
smooth muscle gamma actin
-
-
?
NAD+ + glucose-regulated protein of 78 kDa/immunoglobulin heavy-chainbinding protein L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-glucose-regulated protein of 78 kDa/immunoglobulin heavy-chainbinding protein-L-arginine
-
-
-
?
NAD+ + human neutrophil peptide-1
nicotinamide + Nomega-(ADP-D-ribosyl)-human neutrophil peptide-1
NAD+ + MazF L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-MazF-L-arginine
Tequatrovirus T4
-
the enzyme ADP-ribosylates MazF at an arginine residue at position 4
-
-
?
NAD+ + muscle actin
nicotinamide + H+ + (ADP-ribosyl)-muscle actin
substrate source rabbit skeletal muscle
modification occurs at residue Arg177
-
?
NAD+ + non-muscle actin from human platelets
nicotinamide + (ADP-D-ribosyl)-non-muscle actin from human platelets
-
-
-
-
?
NAD+ + polyarginine
nicotinamide + Nomega-(ADP-D-ribosyl)-polyarginine
-
-
-
?
NAD+ + protein L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-protein-L-arginine
NAD+ + protein poly-L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-protein-poly-L-arginine
-
-
-
?
NAD+ + protein R10H6 L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-protein N10H6-L-arginine
-
-
-
?
NAD+ + rabbit muscle actin
nicotinamide + (ADP-D-ribosyl)-rabbit muscle actin
-
-
-
-
?
NAD+ + [actin]-L-arginine177
nicotinamide + [actin]-N-(ADP-D-ribosyl)-L-arginine177 + H+
nicotinamide + Nomega-(ADP-D-ribosyl)-agmatine-L-arginine
NAD+ + agmatine L-arginine
-
-
-
-
r
ovalbumin + NAD+
nicotinamide + ?
p-nitrobenzylidine aminoguanidine + NAD+
nicotinamide + mono-ADP-ribosylated p-nitrobenzylidine aminoguanidine
P2X7 purinoceptor protein + NAD+
Nomega-[(2'-phospho-ADP)-D-ribosyl]-P2X7 purinoceptor protein-L-arginine + nicotinamide
-
isozyme ART2
-
-
?
P2X7(k) + NAD+
nicotinamide + ?
-
the P2X7(k) variant is sensitive to activation by ADP-ribosylation whereas the P2X7(a) variant is insensitive
-
-
?
P33 + NAD+
nicotinamide + ?
p33 protein + NAD+
nicotinamide + ?
-
-
-
?
polyarginine + NAD+
nicotinamide + ?
polylysine + NAD+
nicotinamide + ?
-
poor ADP-ribose acceptor
-
-
?
Ras + NAD+
nicotinamide + ?
-
ADP-ribosylation of Ras at Arg41 and Arg 128. The double mutant RasR141K/R128K is ribosylated at an alternative sitem Arg135
-
-
?
RhoA + NAD+
Nomega-(ADP-D-ribosyl)-L-asparagine41-RhoA + nicotinamide
-
the enzyme modifies the low-molecular-mass GTPase RhoA specifically at Asn41
-
-
?
RhoB + NAD+
Nomega-(ADP-D-ribosyl)-L-asparagine41-RhoB + nicotinamide
-
the enzyme modifies the low-molecular-mass GTPase RhoB specifically at Asn41
-
-
?
RhoC + NAD+
Nomega-(ADP-D-ribosyl)-L-asparagine41-RhoC + nicotinamide
-
the enzyme modifies the low-molecular-mass GTPase RhoC specifically at Asn41
-
-
?
soy bean trypsin inhibitor + NAD+
nicotinamide + ?
-
-
-
-
?
soybean trypsin inhibitor + NAD+
Nomega-(ADP-D-ribosyl)-L-arginine-soybean trypsin inhibitor + nicotinamide
-
-
-
-
?
trypsin inhibitor + NAD+
nicotinamide + ?
-
-
-
-
?
wild-type exoenzyme C3 + NAD+
Nomega-(ADP-D-ribosyl)-L-arginine86-wild-type exoenzyme C3 + nicotinamide
-
the recombinant mutant Q217E enzyme modifies the recombinant wild-type enzyme at Arg86
-
-
?
additional information
?
-
actin + NAD+

nicotinamide + ?
-
non-muscle beta/gamma actin, skeletal muscle alpha actin, smooth muscle gamma actin
-
-
?
actin + NAD+
nicotinamide + ?
-
alpha-actin and beta/gamma-actin
-
-
?
actin + NAD+
nicotinamide + ?
-
the ADP ribosylation of actin in the heterophils may be involved in the cellular processes such as phagocytosis, secretion and migration
-
-
?
actin + NAD+
nicotinamide + ?
2% of the activity with p33
-
-
?
actin + NAD+
nicotinamide + ?
3% of the activity with p33
-
-
?
actin + NAD+
nicotinamide + ?
-
no activity with the enzyme from skeletal muscle sarcoplasmic reticulum
-
-
?
agmatine + NAD+

nicotinamide + ?
-
-
-
-
?
agmatine + NAD+
nicotinamide + ?
-
-
-
-
?
agmatine + NAD+
nicotinamide + ?
-
-
-
-
?
agmatine + NAD+
nicotinamide + ?
-
-
-
-
?
agmatine + NAD+
nicotinamide + ?
-
-
-
-
?
agmatine + NAD+
nicotinamide + ?
-
-
-
?
basic fibroblast growth factor FGF-2 + NAD+

nicotinamide + ?
-
-
-
-
?
basic fibroblast growth factor FGF-2 + NAD+
nicotinamide + ?
-
-
-
-
?
casein + NAD+

nicotinamide + ?
-
-
-
-
?
casein + NAD+
nicotinamide + ?
8% of the activity with p33
-
-
?
FGF-2 + NAD+

?
-
ADP-ribosylation of FGF-2 may provide an additional level of control of FGF-2 activity
-
-
?
FGF-2 + NAD+
?
-
ADP-ribosylation of FGF-2 may provide an additional level of control of FGF-2 activity
-
-
?
histone + NAD+

nicotinamide + ?
-
-
-
-
?
histone + NAD+
nicotinamide + ?
130% of the activity with p33
-
-
?
histone + NAD+
nicotinamide + ?
67% of the activity with p33
-
-
?
histone + NAD+
nicotinamide + ?
-
-
-
-
?
histone + NAD+
nicotinamide + ?
-
-
-
-
?
human alpha-defensin-1 + NAD+

nicotinamide + ?
-
poorly recognised substrate
-
-
?
human alpha-defensin-1 + NAD+
nicotinamide + ?
-
-
-
-
?
human neutrophil peptide-1 + NAD+

Nomega-(ADP-D-ribosyl)-L-arginine-human neutrophil peptide-1 + nicotinamide
-
human neutrophil peptide-1, HNP-1, from neutrophil cell surface, ADP-ribosylation of HNP-1 is primarily an activity of ART1 and occurs in inflammatory conditions and disease, lack of modified HNP-1 due to enzyme deficiency in the sputum leads to cystic fibrosis
-
-
?
human neutrophil peptide-1 + NAD+
Nomega-(ADP-D-ribosyl)-L-arginine-human neutrophil peptide-1 + nicotinamide
-
human neutrophil peptide-1, HNP-1, from neutrophil cell surface, isozyme ART1 shows high activity on Arg14 and Arg24, while isozymes ART3, ART4, ART5 are less or not active
-
-
?
human neutrophil peptide-1 + NAD+
Nomega-(ADP-D-ribosyl)-L-arginine-human neutrophil peptide-1 + nicotinamide
-
human neutrophil peptide-1, HNP-1, from neutrophil cell surface, isozyme ART1 is active on Arg14 and Arg24
-
-
?
L-arginine methyl ester + NAD+

nicotinamide + Nomega-(ADP-D-ribosyl)-L-arginine
-
-
-
?
L-arginine methyl ester + NAD+
nicotinamide + Nomega-(ADP-D-ribosyl)-L-arginine
-
-
-
-
?
lysozyme + NAD+

nicotinamide + ?
-
-
-
-
?
lysozyme + NAD+
nicotinamide + ?
Tequatrovirus T4
-
-
-
-
?
NAD+ + actin

nicotinamide + H+ + (ADP-ribosyl)-actin
-
Clostridium botulinum C2 toxin ADP-ribosylates actin isoforms gizzard gamma-smooth muscle actin, spleen beta- and gamma-cytoplasmic actin, and gamma-smooth muscle actin isoforms of aortic smooth muscle actin
-
-
?
NAD+ + actin
nicotinamide + H+ + (ADP-ribosyl)-actin
Clostridium perfringens iota toxin ADP-ribosylates all actin isoforms tested, i.e. alpha-skeletal muscle actin, alpha-cardiac muscle actin, gizzard gamma-smooth muscle actin, spleen beta- and gamma-cytoplasmic actin, and aortic smooth muscle actin containing alpha- and gamma-smooth muscle actin isoforms
-
-
?
NAD+ + agmatine

nicotinamide + Nomega-(ADP-D-ribosyl)-agmatine
-
-
-
-
?
NAD+ + agmatine
nicotinamide + Nomega-(ADP-D-ribosyl)-agmatine
-
-
-
-
?
NAD+ + agmatine
nicotinamide + Nomega-(ADP-D-ribosyl)-agmatine
-
the enzyme labels L-arginine with ADP-ribose from the NAD(+) substrate at the amino nitrogen of the guanidinium side chain
-
-
r
NAD+ + human neutrophil peptide-1

nicotinamide + Nomega-(ADP-D-ribosyl)-human neutrophil peptide-1
-
the enzyme ADP-ribosylates human neutrophil peptide-1 on arginine 14 and 24
-
-
?
NAD+ + human neutrophil peptide-1
nicotinamide + Nomega-(ADP-D-ribosyl)-human neutrophil peptide-1
-
the enzyme ADP-ribosylates human neutrophil peptide-1 on arginine 14 and 24
-
-
?
NAD+ + protein L-arginine

nicotinamide + Nomega-(ADP-D-ribosyl)-protein-L-arginine
-
-
-
-
?
NAD+ + protein L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-protein-L-arginine
-
-
-
-
?
NAD+ + protein L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-protein-L-arginine
-
-
-
?
NAD+ + protein L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-protein-L-arginine
-
-
-
-
?
NAD+ + protein L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-protein-L-arginine
-
-
-
-
?
NAD+ + protein L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-protein-L-arginine
-
-
-
?
NAD+ + protein L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-protein-L-arginine
-
-
-
?
NAD+ + protein L-arginine
nicotinamide + Nomega-(ADP-D-ribosyl)-protein-L-arginine
-
-
-
?
NAD+ + [actin]-L-arginine177

nicotinamide + [actin]-N-(ADP-D-ribosyl)-L-arginine177 + H+
-
-
-
?
NAD+ + [actin]-L-arginine177
nicotinamide + [actin]-N-(ADP-D-ribosyl)-L-arginine177 + H+
-
-
-
-
?
NAD+ + [actin]-L-arginine177
nicotinamide + [actin]-N-(ADP-D-ribosyl)-L-arginine177 + H+
-
-
-
-
?
NAD+ + [actin]-L-arginine177
nicotinamide + [actin]-N-(ADP-D-ribosyl)-L-arginine177 + H+
-
-
-
-
?
NAD+ + [actin]-L-arginine177
nicotinamide + [actin]-N-(ADP-D-ribosyl)-L-arginine177 + H+
-
-
-
?
NAD+ + [actin]-L-arginine177
nicotinamide + [actin]-N-(ADP-D-ribosyl)-L-arginine177 + H+
-
-
-
-
?
ovalbumin + NAD+

nicotinamide + ?
-
-
-
-
?
ovalbumin + NAD+
nicotinamide + ?
-
poor ADP-ribose acceptor
-
-
?
p-nitrobenzylidine aminoguanidine + NAD+

nicotinamide + mono-ADP-ribosylated p-nitrobenzylidine aminoguanidine
-
-
-
?
p-nitrobenzylidine aminoguanidine + NAD+
nicotinamide + mono-ADP-ribosylated p-nitrobenzylidine aminoguanidine
-
-
-
?
P33 + NAD+

nicotinamide + ?
-
preferential endogenous acceptor
-
-
?
P33 + NAD+
nicotinamide + ?
-
no activity with the enzyme from skeletal muscle sarcoplasmic reticulum
-
-
?
polyarginine + NAD+

nicotinamide + ?
-
-
-
-
?
polyarginine + NAD+
nicotinamide + ?
in contrast to its mammalian orthologues, the chicken protein contains an intact R-S-EXE motif
-
-
?
polyarginine + NAD+
nicotinamide + ?
-
-
-
-
?
polyarginine + NAD+
nicotinamide + ?
-
-
-
-
?
polyarginine + NAD+
nicotinamide + ?
Tequatrovirus T4
-
-
-
-
ir
additional information

?
-
-
no substrates: alpha-skeletal muscle actin, alpha-smooth muscle actin or alpha-cardiac muscle actin. The N-terminal region of actin isoforms define the substrate specificity for ADP-ribosylation by Clostridium botulinum C2 toxin
-
-
?
additional information
?
-
in absence of actin, enzyme displays weak NAD+ glycohydrolase activity
-
-
?
additional information
?
-
-
the enzyme exhibits ADP-ribosyltransferase and NAD+ glycohydrolase activity, modeling of interaction od substrate and catalytic residues, overview
-
-
?
additional information
?
-
-
enzyme is involved in posttranslational modification of proteins
-
-
?
additional information
?
-
-
substrate specificity, beta-defensin-1 is a poor substrate, overview